hawkguy2018
讚了
$Cadrenal Therapeutics(CVKD.US$ Current Price target:
Noble Capital Markets Initiates Coverage on Cadrenal Therapeutics with Outperform Rating and US$4.00 Price Target
Noble Capital Markets Initiates Coverage on Cadrenal Therapeutics with Outperform Rating and US$4.00 Price Target
3
hawkguy2018
讚了